Serum oncostatin M predicts mucosal healing in patients with inflammatory bowel diseases treated with anti-TNF, but not vedolizumab.
Bertani L, Barberio B, Fornili M, Antonioli L, Zanzi F, Casadei C, Benvenuti L, Facchin S, D'Antongiovanni V, Lorenzon G, Ceccarelli L, Baglietto L, de Bortoli N, Bellini M, Costa F, Savarino EV, Fornai M.
Bertani L, et al. Among authors: casadei c.
Dig Liver Dis. 2022 Oct;54(10):1367-1373. doi: 10.1016/j.dld.2022.03.008. Epub 2022 Apr 4.
Dig Liver Dis. 2022.
PMID: 35393259